Money
FDA-UniQure Tussle and Pfizer's Obesity Drug Approval in China
China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded.
Editorial Staff
1 min read
This update tracks the latest on: FDA-UniQure Tussle and Pfizer's Obesity Drug Approval in China.
Core facts are being consolidated from primary reporting and official statements.
Editorial updates will add context as new verified details emerge.